- Patent Title: Thioxanthone-based autophagy inhibitor therapies to treat cancer
-
Application No.: US13043333Application Date: 2011-03-08
-
Publication No.: US08524762B2Publication Date: 2013-09-03
- Inventor: Steffan Nawrocki , Jennifer Carew , Guru Reddy
- Applicant: Steffan Nawrocki , Jennifer Carew , Guru Reddy
- Applicant Address: US CA Irvine
- Assignee: Spectrum Pharmaceuticals, Inc.
- Current Assignee: Spectrum Pharmaceuticals, Inc.
- Current Assignee Address: US CA Irvine
- Agency: K&L Gates LLP
- Agent Louis C. Cullman; Hal Gibson
- Main IPC: A61K31/38
- IPC: A61K31/38
Abstract:
The present specification provides compositions comprising a thioxanthone-based autophagy inhibitor and/or a cancer therapeutic autophagy inducing compound, pharmaceutical kits comprising these compositions, and methods of treating cancer using such compounds, compositions and kits. Additionally, the present specification provides methods of treating cancer using a thioxanthone-based autophagy inhibitor and a radiotherapy.
Public/Granted literature
- US20110275696A1 Thioxanthone-Based Autophagy Inhibitor Therapies to Treat Cancer Public/Granted day:2011-11-10
Information query
